WaferGen SmartChip System to be Used in Wound Drug Research | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that its SmartChip Real-Time PCR System will be used in preclinical and clinical studies of ImmuneRegen's wound-healing drug candidate Homspera.

The studies will be carried out by researchers at the University of Texas Southwestern Medical Center. They will use the SmartChip system to validate relevant gene expression biomarkers and to assess their impact on patient response to treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.